Publication:
The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival

Simple item page
dc.contributor.authorsCetin, B.; Tastekin, D.; Aktas, B.; Guler, T.; Kaplan, M. A.; Berk, V.; Gumusay, O.; Dane, F.; Ozkan, M.; Benekli, M.
dc.date.accessioned2022-03-12T16:14:24Z
dc.date.accessioned2026-01-11T11:48:59Z
dc.date.available2022-03-12T16:14:24Z
dc.date.issued2013
dc.identifier.doidoiWOS:000326843604074
dc.identifier.eissn1879-0852
dc.identifier.issn0959-8049
dc.identifier.urihttps://hdl.handle.net/11424/225344
dc.identifier.wosWOS:000326843604074
dc.language.isoeng
dc.publisherELSEVIER SCI LTD
dc.relation.ispartofEUROPEAN JOURNAL OF CANCER
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS632
oaire.citation.startPageS632
oaire.citation.titleEUROPEAN JOURNAL OF CANCER
oaire.citation.volume49

Files

Collections

Araştırma Çıktıları